PIERMATTEO, LORENZO
PIERMATTEO, LORENZO
Dipartimento di Biologia
A high degree of genetic variability characterises HDV sub-genotypes 1 and can drive the selection of divergent genetic pathways modulating HDV replicative potential and cytolytic activity.
2025-01-01 Piermatteo, L; Torre, G; Carioti, L; D’Anna, S; Magnapera, A; Khan, S; Etogo, L; Bertoli, A; Paba, P; Olivero, A; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Cillo, U; Vitale, A; Brancaccio, G; Battista Gaeta, G; Ciancio, A; Ceccherini-Silberstein, F; Grelli, S; Sarmati, L; Lampertico, P; Rizzetto, M; Paolo Caviglia, G; Salpini, R; Svicher, V
A Hyper-Glycosylation of HBV Surface Antigen Correlates with HBsAg-Negativity at Immunosuppression-Driven HBV Reactivation in Vivo and Hinders HBsAg Recognition in Vitro
2020-02-23 Salpini, R; Piermatteo, L; Battisti, A; Colagrossi, L; Aragri, M; Yu La Rosa, K; Bertoli, A; Saccomandi, P; Lichtner, M; Marignani, M; Maylin, S; Delaugerre, C; Morisco, F; Coppola, N; Marrone, A; Iapadre, N; Cerva, C; Aquaro, S; Angelico, M; Sarmati, L; Andreoni, M; Verheyen, J; Ceccherini-Silberstein, F; Levrero, M; Perno, Cf; Belloni, L; Svicher, V
A peculiar HBsAg isoforms composition characterizes chronic HDV coinfection respect to HBV mono-infection, with higher middle-/large-HBs levels paralleling HDV activity.
2024-01-01 Magnapera, A; Piermatteo, L; D’Anna, S; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Ceccherini-Silberstein, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, Gp; Svicher, V; Salpini., R
A snapshot of virological presentation and outcome of immunosuppression-driven HBV reactivation from real clinical practice: Evidence of a relevant risk of death and evolution from silent to chronic infection
2019-07-26 Salpini, R; Battisti, A; Colagrossi, L; Di Carlo, D; Fabeni, L; Piermatteo, L; Cerva, C; Lichtner, M; Mastroianni, C; Marignani, M; Maylin, S; Delaugerre, C; Morisco, F; Coppola, N; Marrone, A; Angelico, M; Sarmati, L; Andreoni, M; Perno, C-; Ceccherini-Silberstein, F; Svicher, V
Acquisition of positively charged amino acids in HBsAg C-terminus correlates with HBV-induced liver cancer, hampers HBsAg stability and secretion and promotes cell survival
2022-01-01 Piermatteo, L; Carioti, L; Leoni, G; Duca, L; Saccomandi, P; Stella, D; Andreassi, E; Bertoli, A; Cappiello, G; Fleury, H; Svicher, V; Salpini, R
An in-depth characterization of VOCs circulation by using NGS analysis of the Spike protein.
2022-01-01 Bellocchi, Mc; Carioti, L; Scutari, R; Iannetta, M; Piermatteo, L; Alkhatib, M; Tedde, S; Duca, L; Coppola, L; Malagnino, V; Crea, A; Ansaldo, L; D’Anna, S; Santoro, Mm; Bertoli, A; Di Lorenzo, A; Salpini, R; Svicher, V; Teti, E; Braccialarghe, N; Cavasio, Ra; Sarmati, L; Andreoni, M; Ceccherini-Silberstein, F
An increase in the levels of middle surface antigen characterizes patients developing HBV-driven liver cancer despite prolonged virological suppression
2021-04-02 Brancaccio, G; Salpini, R; Piermatteo, L; Surdo, M; Fini, V; Colagrossi, L; Cantone, M; Battisti, A; Oda, Y; Di Carlo, D; Ceccherini-Silberstein, F; Perno, Cf; Gaeta, Gb; Svicher, V
An increased genetic variability characterises HDV sub-genotypes 1 and can drive the selection of divergent genetic pathways modulating HDV replicative potential and cytolytic activity
2025-01-01 Piermatteo, L; Torre, G; Carioti, L; D’Anna, S; Magnapera, A; Khan, S; Etogo, L; Bertoli, A; Paba, P; Olivero, A; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Cillo, U; Vitale, A; Brancaccio, G; Battista Gaeta, G; Ciancio, A; Ceccherini-Silberstein, F; Grelli, S; Sarmati, L; Lampertico, P; Rizzetto, M; Paolo Caviglia, G; Salpini, R; Svicher, V
Biological and clinical significance of classic and innovative virological parameters in the pathogenesis and in the clinical management of HBV infection
2019-01-01 Piermatteo, L
Caratterizzazione intraepatica dell'attività di HDV sostenuta dall'integrazione di HBV al baseline e sotto trattamento.
2025-01-01 Grossi, I; D'Anna, S; Di Lorenzo, A; Piermatteo, L; Ceccherini Silberstein, F; Sarmati, L; Salpini, R; Svicher, V
Chronic HDV coinfection (CHD) is characterized by a different HBsAg isoforms composition respect to HBV mono-infection with higher middle- and large-HBs levels paralleling the replicative and cytolytic activity of HDV.
2024-01-01 Magnapera, 1a; Piermatteo, L; D’Anna, S; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Ceccherini-Silberstein, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, G; Salpini, R; Svicher, V
Chronic HDV coinfection is characterized by a more elevated production of all three HBsAg isoforms compared to HBV mono-infection, that parallels HDV replicative and cytolytic activity.
2025-01-01 D’Anna, S; Piermatteo, L; Magnapera, A; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, L; Milella, M; Saracino, Al; Ciancio, Al; Silberstein, C; F, ; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, Gp; Svicher, V; Salpini, R
Chronic HDV coinfection is characterized by a peculiar HBsAg isoforms composition respect to HBV mono-infection, with higher middle-/large-HBs levels paralleling HDV activity.
2024-01-01 Magnapera, A; Piermatteo, L; D’Anna, S; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Ceccherini-Silberstein, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, G; Svicher, V; Salpini, R
Chronic HDV infection is sustained by an intense HBsAg production fromintegrated HBVDNA in the setting of a limited or even absent HBV reservoir.
2024-01-01 Salpini, 1r; D'Anna, S; Piermatteo, L; Brancaccio, G; Teti, E; Di Lorenzo, A; Grossi, I; Torre, G; Malagnino, V; Iannetta, M; Ceccherini-Silberstein, F; Pasquazzi, C; Cillo, U; Vitale, A; Gringeri, E; Magrofuoco, M; Pacenti, M; Baiocchi, L; Francioso, S; Lenci, I; Koffas, A; Geretti, A; Abate, Ml; Olivero, A; Gaeta, G; Sarmati, L; Rizzetto, M; Gill, U; Kennedy, P; Caviglia, Gp; Svicher., V
Circulation of sars-cov-2 variants in central Italy: spike variability characterization by deep-sequencing.
2022-01-01 Bellocchi, M; Carioti, L; Scutari, R; Iannetta, M; Piermatteo, L; Alkhatib, M; Tedde, S; Duca, L; Coppola, L; Malagnino, V; Crea, A; Ansaldo, L; D’Anna, S; Santoro, Mm; Bertoli, A; Di Lorenzo, A; Salpini, R; Svicher, V; Teti, E; Braccialarghe, N; Cavasio, Ra; Sarmati, L; Andreoni, M; Ceccherini Silberstein, F
Clinical and laboratory parameters correlated to HDV undetectability after 48 weeks of bulevirtide
2025-01-01 Di Lorenzo, N; D’Anna, S; Kontogiannis, D; Sorace, C; Crea, A; Teti, E; Malagnino, V; Piermatteo, L; Grossi, I; Castelli, C; Carreri, B; Nezzo, M; Salbuzzi, F; Iannetta, M; Geretti, A; Svicher, V; Salpini, R; Sarmati, L
Comparison of diagnostic performances of HDV-RNA quantification assays used in clinical practice: Results from a national quality control multicenter study
2025-10-01 Salpini, R; Piermatteo, L; Caviglia, Gp; Bertoli, A; Brunetto, Mr; Bruzzone, B; Callegaro, A; Caudai, C; Cavallone, D; Chessa, L; Coghe, F; Coppola, N; Cuomo, N; D'Anna, S; Di Stefano, M; Facchetti, F; Farina, C; Ferraro, D; Franchin, E; Francisci, D; Galli, S; Garbuglia, Ar; Gennari, W; Ghisetti, V; Lampertico, P; Lo Caputo, S; Marascio, N; Menzo, S; Micheli, V; Niro, Ga; Olivero, A; Paba, P; Palermo, Ci; Palmieri, O; Paolucci, S; Pisaturo, M; Pollicino, T; Raffa, G; Santantonio, T; Torre, G; Turriziani, O; Uzzau, S; Uceda Renteria, Sc; Vatteroni, M; Zazzi, M; Craxì, A; Ceccherini-Silberstein, F; Svicher, V; Arosio, M; Bastianelli, S; Gentile, A; Giardina, Fam; Gidari, A; Govoni, R; Ibba, G; Loglio, A; Lombardi, A; Mascarella, C; Maggi, F; Matera, G; Mazzei, C; Milia, Mg; Quirino, A; Raddi, A; Scioscia, R; Tagliazucchi, S; Totaro, M; Valaperta, R
Cryptic HBV activity is frequently observed among anti-HBc positive/HBsAg negative people living with HIV infection during HBV-active art and can jeopardize the full control of HIV replication.
2024-01-01 Piermatteo, L; Salpini, R; D’Anna, S; Castelli, C; Grossi, I; Mulas, T; Di Lorenzo, A; Bertoli, A; Iannetta, M; Sarmati, L; Svicher, V; Malagnino., V
Cryptic HBV replicative activity is frequently revealed in anti-HBC-positive/hbsag-negative patients with HIV infection by highly sensitive molecular assays, and can be predicted by integrating classical and novel serological HBV markers
2020-01-01 Salpini, R; Malagnino, V; Piermatteo, L; Mulas, T; Alkhatib, M; Scutari, R; Teti, E; Cerva, C; Yu La Rosa, K; Brugneti, M; Bertoli, A; Rossi, B; Holzmayer, V; Gersch, J; Kuhns, M; Cloherty, G; Ceccherini Silberstein, F; Perno, C; Iannetta, M; Andreoni, M; Sarmati, L; Svicher, V
Despite a substantial burden of HDV infection, gaps in HDV screening still persists across Europe: an urgent need to strengthen diagnostic strategies at pan-European level
2025-01-01 Salpini, R; Grossi, I; Alexiev, I; Baiocchi, L; Banica, L; Begovac, J; Benkoova, B; Bopegamage, S; Castelli, C; Caudai, C; D’Anna, S; Demir, T; Devaux, C; Di Lorenzo, A; Heger, E; Kaiser, R; Kokkinos, N; Fernandez-Rivas, G; Gazdikova, K; Geretti, Am; Golkocheva-Markova, E; Iserentant, G; Lazarevic, I; Lazureanu, V; Leuzinger, K; Lindh, M; Llibre, Jm; Lunar, Mm; Mihale, J; Mor, O; Nierhoff, D; Otelea, D; Piermatteo, L; Poljak, M; Riccio, Arm; Sarmati, L; Torre, G; Tudor, Am; Vata, A; Yildiran, D; Zazzi, M; Wensing, Amj; Svicher, V
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-gen-2025 | A high degree of genetic variability characterises HDV sub-genotypes 1 and can drive the selection of divergent genetic pathways modulating HDV replicative potential and cytolytic activity. | Piermatteo, L; Torre, G; Carioti, L; D’Anna, S; Magnapera, A; Khan, S; Etogo, L; Bertoli, A; Paba, P; Olivero, A; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Cillo, U; Vitale, A; Brancaccio, G; Battista Gaeta, G; Ciancio, A; Ceccherini-Silberstein, F; Grelli, S; Sarmati, L; Lampertico, P; Rizzetto, M; Paolo Caviglia, G; Salpini, R; Svicher, V | Intervento a convegno | |
| 23-feb-2020 | A Hyper-Glycosylation of HBV Surface Antigen Correlates with HBsAg-Negativity at Immunosuppression-Driven HBV Reactivation in Vivo and Hinders HBsAg Recognition in Vitro | Salpini, R; Piermatteo, L; Battisti, A; Colagrossi, L; Aragri, M; Yu La Rosa, K; Bertoli, A; Saccomandi, P; Lichtner, M; Marignani, M; Maylin, S; Delaugerre, C; Morisco, F; Coppola, N; Marrone, A; Iapadre, N; Cerva, C; Aquaro, S; Angelico, M; Sarmati, L; Andreoni, M; Verheyen, J; Ceccherini-Silberstein, F; Levrero, M; Perno, Cf; Belloni, L; Svicher, V | Articolo su rivista | |
| 1-gen-2024 | A peculiar HBsAg isoforms composition characterizes chronic HDV coinfection respect to HBV mono-infection, with higher middle-/large-HBs levels paralleling HDV activity. | Magnapera, A; Piermatteo, L; D’Anna, S; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Ceccherini-Silberstein, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, Gp; Svicher, V; Salpini., R | Intervento a convegno | |
| 26-lug-2019 | A snapshot of virological presentation and outcome of immunosuppression-driven HBV reactivation from real clinical practice: Evidence of a relevant risk of death and evolution from silent to chronic infection | Salpini, R; Battisti, A; Colagrossi, L; Di Carlo, D; Fabeni, L; Piermatteo, L; Cerva, C; Lichtner, M; Mastroianni, C; Marignani, M; Maylin, S; Delaugerre, C; Morisco, F; Coppola, N; Marrone, A; Angelico, M; Sarmati, L; Andreoni, M; Perno, C-; Ceccherini-Silberstein, F; Svicher, V | Articolo su rivista | |
| 1-gen-2022 | Acquisition of positively charged amino acids in HBsAg C-terminus correlates with HBV-induced liver cancer, hampers HBsAg stability and secretion and promotes cell survival | Piermatteo, L; Carioti, L; Leoni, G; Duca, L; Saccomandi, P; Stella, D; Andreassi, E; Bertoli, A; Cappiello, G; Fleury, H; Svicher, V; Salpini, R | Articolo su rivista | |
| 1-gen-2022 | An in-depth characterization of VOCs circulation by using NGS analysis of the Spike protein. | Bellocchi, Mc; Carioti, L; Scutari, R; Iannetta, M; Piermatteo, L; Alkhatib, M; Tedde, S; Duca, L; Coppola, L; Malagnino, V; Crea, A; Ansaldo, L; D’Anna, S; Santoro, Mm; Bertoli, A; Di Lorenzo, A; Salpini, R; Svicher, V; Teti, E; Braccialarghe, N; Cavasio, Ra; Sarmati, L; Andreoni, M; Ceccherini-Silberstein, F | Intervento a convegno | |
| 2-apr-2021 | An increase in the levels of middle surface antigen characterizes patients developing HBV-driven liver cancer despite prolonged virological suppression | Brancaccio, G; Salpini, R; Piermatteo, L; Surdo, M; Fini, V; Colagrossi, L; Cantone, M; Battisti, A; Oda, Y; Di Carlo, D; Ceccherini-Silberstein, F; Perno, Cf; Gaeta, Gb; Svicher, V | Articolo su rivista | |
| 1-gen-2025 | An increased genetic variability characterises HDV sub-genotypes 1 and can drive the selection of divergent genetic pathways modulating HDV replicative potential and cytolytic activity | Piermatteo, L; Torre, G; Carioti, L; D’Anna, S; Magnapera, A; Khan, S; Etogo, L; Bertoli, A; Paba, P; Olivero, A; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Cillo, U; Vitale, A; Brancaccio, G; Battista Gaeta, G; Ciancio, A; Ceccherini-Silberstein, F; Grelli, S; Sarmati, L; Lampertico, P; Rizzetto, M; Paolo Caviglia, G; Salpini, R; Svicher, V | Intervento a convegno | |
| 1-gen-2019 | Biological and clinical significance of classic and innovative virological parameters in the pathogenesis and in the clinical management of HBV infection | Piermatteo, L | Tesi di dottorato | |
| 1-gen-2025 | Caratterizzazione intraepatica dell'attività di HDV sostenuta dall'integrazione di HBV al baseline e sotto trattamento. | Grossi, I; D'Anna, S; Di Lorenzo, A; Piermatteo, L; Ceccherini Silberstein, F; Sarmati, L; Salpini, R; Svicher, V | Intervento a convegno | |
| 1-gen-2024 | Chronic HDV coinfection (CHD) is characterized by a different HBsAg isoforms composition respect to HBV mono-infection with higher middle- and large-HBs levels paralleling the replicative and cytolytic activity of HDV. | Magnapera, 1a; Piermatteo, L; D’Anna, S; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Ceccherini-Silberstein, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, G; Salpini, R; Svicher, V | Intervento a convegno | |
| 1-gen-2025 | Chronic HDV coinfection is characterized by a more elevated production of all three HBsAg isoforms compared to HBV mono-infection, that parallels HDV replicative and cytolytic activity. | D’Anna, S; Piermatteo, L; Magnapera, A; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, L; Milella, M; Saracino, Al; Ciancio, Al; Silberstein, C; F, ; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, Gp; Svicher, V; Salpini, R | Intervento a convegno | |
| 1-gen-2024 | Chronic HDV coinfection is characterized by a peculiar HBsAg isoforms composition respect to HBV mono-infection, with higher middle-/large-HBs levels paralleling HDV activity. | Magnapera, A; Piermatteo, L; D’Anna, S; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Ceccherini-Silberstein, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, G; Svicher, V; Salpini, R | Intervento a convegno | |
| 1-gen-2024 | Chronic HDV infection is sustained by an intense HBsAg production fromintegrated HBVDNA in the setting of a limited or even absent HBV reservoir. | Salpini, 1r; D'Anna, S; Piermatteo, L; Brancaccio, G; Teti, E; Di Lorenzo, A; Grossi, I; Torre, G; Malagnino, V; Iannetta, M; Ceccherini-Silberstein, F; Pasquazzi, C; Cillo, U; Vitale, A; Gringeri, E; Magrofuoco, M; Pacenti, M; Baiocchi, L; Francioso, S; Lenci, I; Koffas, A; Geretti, A; Abate, Ml; Olivero, A; Gaeta, G; Sarmati, L; Rizzetto, M; Gill, U; Kennedy, P; Caviglia, Gp; Svicher., V | Intervento a convegno | |
| 1-gen-2022 | Circulation of sars-cov-2 variants in central Italy: spike variability characterization by deep-sequencing. | Bellocchi, M; Carioti, L; Scutari, R; Iannetta, M; Piermatteo, L; Alkhatib, M; Tedde, S; Duca, L; Coppola, L; Malagnino, V; Crea, A; Ansaldo, L; D’Anna, S; Santoro, Mm; Bertoli, A; Di Lorenzo, A; Salpini, R; Svicher, V; Teti, E; Braccialarghe, N; Cavasio, Ra; Sarmati, L; Andreoni, M; Ceccherini Silberstein, F | Articolo su rivista | |
| 1-gen-2025 | Clinical and laboratory parameters correlated to HDV undetectability after 48 weeks of bulevirtide | Di Lorenzo, N; D’Anna, S; Kontogiannis, D; Sorace, C; Crea, A; Teti, E; Malagnino, V; Piermatteo, L; Grossi, I; Castelli, C; Carreri, B; Nezzo, M; Salbuzzi, F; Iannetta, M; Geretti, A; Svicher, V; Salpini, R; Sarmati, L | Intervento a convegno | |
| 1-ott-2025 | Comparison of diagnostic performances of HDV-RNA quantification assays used in clinical practice: Results from a national quality control multicenter study | Salpini, R; Piermatteo, L; Caviglia, Gp; Bertoli, A; Brunetto, Mr; Bruzzone, B; Callegaro, A; Caudai, C; Cavallone, D; Chessa, L; Coghe, F; Coppola, N; Cuomo, N; D'Anna, S; Di Stefano, M; Facchetti, F; Farina, C; Ferraro, D; Franchin, E; Francisci, D; Galli, S; Garbuglia, Ar; Gennari, W; Ghisetti, V; Lampertico, P; Lo Caputo, S; Marascio, N; Menzo, S; Micheli, V; Niro, Ga; Olivero, A; Paba, P; Palermo, Ci; Palmieri, O; Paolucci, S; Pisaturo, M; Pollicino, T; Raffa, G; Santantonio, T; Torre, G; Turriziani, O; Uzzau, S; Uceda Renteria, Sc; Vatteroni, M; Zazzi, M; Craxì, A; Ceccherini-Silberstein, F; Svicher, V; Arosio, M; Bastianelli, S; Gentile, A; Giardina, Fam; Gidari, A; Govoni, R; Ibba, G; Loglio, A; Lombardi, A; Mascarella, C; Maggi, F; Matera, G; Mazzei, C; Milia, Mg; Quirino, A; Raddi, A; Scioscia, R; Tagliazucchi, S; Totaro, M; Valaperta, R | Articolo su rivista | |
| 1-gen-2024 | Cryptic HBV activity is frequently observed among anti-HBc positive/HBsAg negative people living with HIV infection during HBV-active art and can jeopardize the full control of HIV replication. | Piermatteo, L; Salpini, R; D’Anna, S; Castelli, C; Grossi, I; Mulas, T; Di Lorenzo, A; Bertoli, A; Iannetta, M; Sarmati, L; Svicher, V; Malagnino., V | Intervento a convegno | |
| 1-gen-2020 | Cryptic HBV replicative activity is frequently revealed in anti-HBC-positive/hbsag-negative patients with HIV infection by highly sensitive molecular assays, and can be predicted by integrating classical and novel serological HBV markers | Salpini, R; Malagnino, V; Piermatteo, L; Mulas, T; Alkhatib, M; Scutari, R; Teti, E; Cerva, C; Yu La Rosa, K; Brugneti, M; Bertoli, A; Rossi, B; Holzmayer, V; Gersch, J; Kuhns, M; Cloherty, G; Ceccherini Silberstein, F; Perno, C; Iannetta, M; Andreoni, M; Sarmati, L; Svicher, V | Articolo su rivista | |
| 1-gen-2025 | Despite a substantial burden of HDV infection, gaps in HDV screening still persists across Europe: an urgent need to strengthen diagnostic strategies at pan-European level | Salpini, R; Grossi, I; Alexiev, I; Baiocchi, L; Banica, L; Begovac, J; Benkoova, B; Bopegamage, S; Castelli, C; Caudai, C; D’Anna, S; Demir, T; Devaux, C; Di Lorenzo, A; Heger, E; Kaiser, R; Kokkinos, N; Fernandez-Rivas, G; Gazdikova, K; Geretti, Am; Golkocheva-Markova, E; Iserentant, G; Lazarevic, I; Lazureanu, V; Leuzinger, K; Lindh, M; Llibre, Jm; Lunar, Mm; Mihale, J; Mor, O; Nierhoff, D; Otelea, D; Piermatteo, L; Poljak, M; Riccio, Arm; Sarmati, L; Torre, G; Tudor, Am; Vata, A; Yildiran, D; Zazzi, M; Wensing, Amj; Svicher, V | Intervento a convegno |